JP2016507547A5 - - Google Patents

Download PDF

Info

Publication number
JP2016507547A5
JP2016507547A5 JP2015556566A JP2015556566A JP2016507547A5 JP 2016507547 A5 JP2016507547 A5 JP 2016507547A5 JP 2015556566 A JP2015556566 A JP 2015556566A JP 2015556566 A JP2015556566 A JP 2015556566A JP 2016507547 A5 JP2016507547 A5 JP 2016507547A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
composition according
combination
administered
ceftazidime
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015556566A
Other languages
English (en)
Japanese (ja)
Other versions
JP6383367B2 (ja
JP2016507547A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/GB2014/050354 external-priority patent/WO2014122468A1/en
Publication of JP2016507547A publication Critical patent/JP2016507547A/ja
Publication of JP2016507547A5 publication Critical patent/JP2016507547A5/ja
Application granted granted Critical
Publication of JP6383367B2 publication Critical patent/JP6383367B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015556566A 2013-02-06 2014-02-06 院内肺炎の処置のための併用療法 Active JP6383367B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361761369P 2013-02-06 2013-02-06
US61/761,369 2013-02-06
PCT/GB2014/050354 WO2014122468A1 (en) 2013-02-06 2014-02-06 Combination therapy for the treatment of nosocomial pneumonia

Publications (3)

Publication Number Publication Date
JP2016507547A JP2016507547A (ja) 2016-03-10
JP2016507547A5 true JP2016507547A5 (cg-RX-API-DMAC7.html) 2017-03-09
JP6383367B2 JP6383367B2 (ja) 2018-08-29

Family

ID=50114393

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015556566A Active JP6383367B2 (ja) 2013-02-06 2014-02-06 院内肺炎の処置のための併用療法

Country Status (13)

Country Link
US (1) US20150374673A1 (cg-RX-API-DMAC7.html)
EP (1) EP2953626A1 (cg-RX-API-DMAC7.html)
JP (1) JP6383367B2 (cg-RX-API-DMAC7.html)
KR (1) KR20150115761A (cg-RX-API-DMAC7.html)
CN (2) CN110302203A (cg-RX-API-DMAC7.html)
AU (1) AU2014213795B2 (cg-RX-API-DMAC7.html)
BR (1) BR112015018360B1 (cg-RX-API-DMAC7.html)
CA (1) CA2897446A1 (cg-RX-API-DMAC7.html)
CL (1) CL2015002180A1 (cg-RX-API-DMAC7.html)
MX (1) MX2015010077A (cg-RX-API-DMAC7.html)
RU (1) RU2684112C2 (cg-RX-API-DMAC7.html)
UA (1) UA115683C2 (cg-RX-API-DMAC7.html)
WO (1) WO2014122468A1 (cg-RX-API-DMAC7.html)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI690317B (zh) * 2014-11-17 2020-04-11 英商安特西醫療有限公司 用於治療抗藥性細菌感染之組合療法
WO2016156346A1 (en) 2015-03-31 2016-10-06 Mutabilis Heterocyclic compounds and their use in preventing or treating bacterial infections
JP2018515481A (ja) 2015-09-16 2018-06-14 シュアンチュー ファーマ カンパニー,リミティド β−ラクタマーゼ阻害剤とその利用
US20200316083A1 (en) * 2016-06-17 2020-10-08 Wockhardt Limited Antibacterial compositions
PT3512851T (pt) 2016-09-16 2022-10-11 Entasis Therapeutics Ltd Compostos inibidores de beta-lactamase
US10434089B2 (en) 2017-01-25 2019-10-08 The Johns Hopkins University Avibactam and carbapenems antibacterial agents
SMT202200110T1 (it) 2017-05-08 2022-05-12 Entasis Therapeutics Inc Composti e metodi per trattare infezioni batteriche
FI3833665T3 (fi) 2018-08-09 2023-10-09 Antabio Sas Diatsabisyklo-oktanoneja seriini-beeta-laktamaasien inhibiittoreina
US11905286B2 (en) 2018-08-09 2024-02-20 Antabio Sas Diazabicyclooctanones as inhibitors of serine beta-lactamases
RU2746833C1 (ru) * 2020-08-03 2021-04-21 Федеральное государственное бюджетное образовательное учреждение высшего образования "Волгоградский государственный медицинский университет" Министерства здравоохранения Российской Федерации ФГБОУ ВО ВолгГМУ МЗ РФ Способ моделирования экспериментального воспаления легких у крыс
CN113413367A (zh) * 2021-08-16 2021-09-21 浙江尖峰药业有限公司 一种注射用阿维巴坦头孢甲肟复方粉针及其制备方法
GB202306826D0 (en) 2023-05-09 2023-06-21 Adjutec Pharma As Therapy
CN119818504A (zh) * 2025-01-04 2025-04-15 重庆圣华曦药业股份有限公司 一种头孢哌酮和阿维巴坦的抗菌组合物及其用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1861110B1 (en) * 2004-12-17 2014-03-26 Venus Remedies Limited Antibiotic combinations for providing total solution to the treatment of infections
CN101074235B (zh) * 2006-05-15 2010-05-12 中国药品生物制品检定所 头孢硫脒醇水化合物及其制备方法
CN101245080A (zh) * 2007-02-14 2008-08-20 山东轩竹医药科技有限公司 含有吡唑并三唑的头孢菌素衍生物
JP2012522009A (ja) * 2009-03-26 2012-09-20 パルマトリックス,インコーポレイテッド 肺炎および人工呼吸器関連気管気管支炎を治療および予防するための方法

Similar Documents

Publication Publication Date Title
JP2016507547A5 (cg-RX-API-DMAC7.html)
RU2015132369A (ru) Комбинированная терапия для лечения нозокомиальной пневмонии
MX385731B (es) Compuestos de biaril-monobactam y métodos de uso de los mismos para el tratamiento de infecciones bacterianas.
BR112015027699A2 (pt) Uso de robenidina ou um sal terapeuticamente aceitável da mesma, composição farmacêutica antibacteriana e dispositivo médico
CY1119490T1 (el) Παραγωγα πυραζολοπυρρολιδινης και η χρηση τους στην θεραπεια νοσηματων
JP2015528502A5 (cg-RX-API-DMAC7.html)
HRP20250119T1 (hr) Kdm1a inhibitor i njegova primjena u terapiji
NZ617104A (en) Pharmaceutical compositions comprising beta-lactam antibiotic, sulbactam and beta-lactamase inhibitor
CL2013002417A1 (es) Compuestos derivados de fluoropiridinona; composición farmacéutica que los comprende; y su uso en el tratamiento de infecciones bacterianas.
BR112015003188A2 (pt) Composto, composição farmacêutica, uso do composto e método para tratar uma doença ou condição mediada por rorgammat em um paciente
CR20170605A (es) DERIVADOS DE 3-TETRAZOLIL-BENCENO-1,2-DISULFONAMIDA COMO INHIBIDORES DE METALO -ß-LACTAMASA
MX338610B (es) Composiciones farmaceuticas que comprenden sulbactam e inhibidor de beta-lactamasa.
BR112018067930A2 (pt) composto, sal de ácido trifluoroacético, composição farmacêutica, método para tratamento de uma infecção bacteriana, e, uso de um composto.
MX2017012545A (es) Compuestos heterociclicos y su uso en la prevencion o tratamiento de las infecciones bacterianas.
CL2015002755A1 (es) Composiciones antibióticas de ceftolozano.
WO2016100578A3 (en) Antimicrobial polymyxins for treatment of bacterial infections
EA201792566A1 (ru) Замещенные фенилоксазолидиноны для антимикробной терапии
EA201790726A1 (ru) Фармацевтическая композиция для лечения язвенного колита
JP2015537009A5 (cg-RX-API-DMAC7.html)
SA518390825B1 (ar) مضاد حيوي جديد فعال من أمينو جلايكوسيد للبكتيريا المضادة لعقاقير متعددة
EA201692111A1 (ru) Фармацевтические композиции, содержащие данириксин, для лечения инфекционных заболеваний
MX2017012535A (es) Compuestos hetorociclicos novedosos y su uso en la prevencion o tratamiento de las infecciones bacterianas.
EA201890412A1 (ru) АНТИБАКТЕРИАЛЬНЫЕ АГЕНТЫ, СОДЕРЖАЩИЕ ПИРАЗИНО[2,3-b][1,4]ОКСАЗИН-3-ОН ИЛИ РОДСТВЕННУЮ КОЛЬЦЕВУЮ СИСТЕМУ
BR112017005828A2 (pt) métodos para tratar ou prevenir uma infecção respiratória, copd e uma exacerbação de copd e para selecionar um inibidor de sinalização notch 3 e/ou notch4, usp de um inibidor de sinalização de notch 3 e/ou notch 4, inibidor de sinalização de notch 3 e/ou notch 4, e, composição farmacêutica.
MX2017014080A (es) Compuestos heterociclicos y su uso en la prevencion o tratamiento de las infecciones bacterianas.